Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
Crossref DOI link: https://doi.org/10.1186/1750-1172-10-S1-P6
Published Online: 2015-11-02
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cortese, Andrea
Vita, Giuseppe
Obici, Laura
Sabatelli, Marco
Fabrizi, Gian Maria
Schenone, Angelo
Merlini, Giampaolo
Pareyson, Davide
Text and Data Mining valid from 2015-11-02
Version of Record valid from 2015-11-02
Article History
First Online: 2 November 2015